Henry Schein Inc. (HSIC) News
Filter HSIC News Items
HSIC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HSIC News Highlights
- For HSIC, its 30 day story count is now at 20.
- Over the past 13 days, the trend for HSIC's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- DGX, CTLT and ABT are the most mentioned tickers in articles about HSIC.
Latest HSIC News From Around the Web
Below are the latest news stories about HENRY SCHEIN INC that investors may wish to consider to help them evaluate HSIC as an investment opportunity.
Illumina (ILMN) to Enable Tertiary Analysis With New LaunchIllumina's (ILMN) Connected Software is an end-to-end software system that standardizes analysis tools and connects data across the genomics workflow. |
Surmodics (SRDX) Gets FDA's Formal Feedback About SurVeil DCBSurmodics' (SRDX) receipt of the FDA's positive formal feedback regarding its PMA application for the SurVeil DCB looks promising. |
Henry Schein Announces Presence at the 2023 Association of Dental Support Organizations (ADSO) SummitMELVILLE, N.Y., March 28, 2023--Henry Schein, Inc. (Nasdaq: HSIC) announced its presence at the 2023 ADSO Annual Summit, including thought-leadership presentations on the future of dentistry and intrapreneurship as well as activities to support communities in need. |
Reasons to Retain Quest Diagnostics (DGX) Stock for NowInvestors are optimistic about Quest Diagnostics (DGX) on solid fourth-quarter 2022 performance and its strategies to accelerate growth. |
Is Henry Schein (HSIC) Stock Undervalued Right Now?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
Quest Diagnostics (DGX) Introduces New Post-COVID-19 PanelsQuest Diagnostics' (DGX) latest panels provide consumers a deeper look into their health, helping to prepare them for meaningful discussions with their healthcare providers |
MedTech Bigwigs in Spotlight as AI Revolutionizes HealthcareMedTech player like Medtronic (MDT) are integrating artificial intelligence (AI) capabilities to aid therapeutic and diagnostic applications. |
Catalent (CTLT) Inks Deal for Nasal Spray for Opioid OverdosesCatalent's (CTLT) latest commercial supply agreement is expected to combat the opioid epidemic by making OTC naloxone more widely and easily accessible. |
3 Reasons to Retain QuidelOrtho (QDEL) Stock in Your PortfolioInvestors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio. |
Quest Diagnostics (DGX) Advances Transplant Testing ServiceThese services by Quest Diagnostics (DGX) are available to recipients and living donors across the United States (excluding Alaska and Hawaii), broadening access for both donor and patient. |